TNE: Effectiveness of a Psychoeducative Intervention on Patients With Cronic Low Back Pain

Sponsor
Universidad Miguel Hernandez de Elche (Other)
Overall Status
Recruiting
CT.gov ID
NCT03964389
Collaborator
Hospital Universitario San Juan de Alicante (Other)
120
1
2
8.3
14.5

Study Details

Study Description

Brief Summary

One of the treatment modalities currently available in this hospital to treat this type of patients with low back pain who present with chronic pain are the group sessions that are carried out to provide information to the patient about the anatomy, biomechanics and ergonomics and are complemented with sessions of physical exercise. Based on the latest publications on treatment of this type of patients, The investigators have seen that this intervention is insufficient, and that it could be improved by combining education based on Therapeutic Neuroscience Education (TNE)).

The present study proposes implementing this program to a randomly assigned group of patients participating in the group sessions aimed at patients with lumbar pain called "Back-pain Protocol" that are currently relized in the Physiotherapy Area of a hospital; and compare the results of this intervention with those obtained in another group that will only carry out the sessions with the traditional method that is currently used.

Condition or Disease Intervention/Treatment Phase
  • Other: Therapeutic Neuroscience Education (TNE)
N/A

Detailed Description

Process The physiotherapist responsible for programs group to treat chronic back pain ( "Back-pain Protocol") will be contacted. The study will be explained and material and training will be provided to carry out the TNE session.

Subsequently, participants who meet the inclusion criteria will be detected and assigned to the intervention group or to the control group after a randomisation process.

At the end of the first session that is currently taking place in the programs to treat chronic back pain in groups, the physiotherapist will explain the study and will ask them to collaborate. The information sheet will be provided. Those who decide to participate will receive an informed consent and some questionnaires to complete: the Numeric Pain Rating Scale (NPRS) to assess their degree of pain, the Central Sensitization Inventory, the Pain Catastrophic Scale (Spanish version), the Tampa Kinesiofobia Scale (TSK) "and EuroQol-5D Cuetionario.

Interventions The protocol that is currently carried out consists of five sessions spread over a month and a half. Patients come in two groups of 10 people each day, with a duration of one hour, in the Rehabilitation classroom.

The first session, which consists of an informative talk. The physiotherapist provides information and explanations about the "back pain protocol". The physiotherapist explains the problems of attitude and gestures that can benefit or harm their treatment, their activities of daily life, their work and the performance of sports activities.

In the second, third and fourth sessions, participants learn to do specific exercises for back pain. Patients receive a booklet with the exercises and postures to adopt in the habits of daily life.

In the fifth and final session, a final review of everything learned is done and the final evaluation is requested (the Numeric Pain Rating Scale (NPRS) to assess their degree of pain, the Central Sensitization Inventory, the Catastrophism Scale of the Pain (Spanish version), the Tampa Kinesiofobia Scale (TSK) "and EuroQol-5D Cuetionario).

Treatment. This study proposes that only participants assigned to the intervention group will also receive an additional session of patient education about Therapeutic Neuroscience Education (TNE)

The duration of this session will be one hour and will be carried out the day after the first informative session of the current protocol, in an additional session. In addition, they will be provided with information to read and review at home. Only patients who have been randomly assigned to the intervention group will attend this session.

This intervention aims to provide information in a clear and simple way to the participants so that through it the patients can modify their attitude towards pain, inviting them to assume a more active and less contemplative role. The physiotherapist will explain in a simple way to the participants that chronic pain is not always the result of tissue damage. Neuroscience has shown that it is possible to have persistent pain without damaging the tissues or with damage that justifies the perception of the disproportion of pain. In addition, the physiotherapist will explain the difference between acute pain and chronic pain, central sensitization processes (CS) and endogenous pain control mechanisms. The physiotherapist will talk about how thoughts, beliefs and emotions modify the painful experience and how the erroneous information received, and sometimes iatrogenic, modifies the mechanisms of pain processing. The contents of talks on education in neuroscience are based on the book Explain Pain.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
two-armed randomized trialtwo-armed randomized trial
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participants receive TEN sessions, but do not know that one of the groups will receive extra information
Primary Purpose:
Treatment
Official Title:
Effectiveness of Therapeutic Neuroscience Education (TNE) on Patients Who Are Participating in Therapeutic Exercises Programs to Treat Cronic Low Back Pain: a Two-armed Randomized Trial
Anticipated Study Start Date :
Jan 22, 2021
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervetion group

A sessions of "Therapeutic Neuroscience Education (TNE)" joint a physical exercises programs

Other: Therapeutic Neuroscience Education (TNE)
A talk on Neuroscience Education (EN). This intervention aims to provide information in a clear and simple way to the participants so that through it the patients may be able to modify their attitude towards pain, inviting them to take a more active and less contemplative role. Neuroscience has shown that it is possible to have persistent pain without damage to the tissues or with damage that justifies the perceived disproportion of pain.
Other Names:
  • Pain Neuroscience Education" (PNE)
  • No Intervention: Control group

    Only a therapeutic physical exercises programs

    Outcome Measures

    Primary Outcome Measures

    1. Numeric Pain Rating Scale (NPRS) [6 weeks following the reported onset of symptoms.]

      The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")

    Secondary Outcome Measures

    1. Pain Catastrophizing: Pain Catastrophizing Scale [baseline; 1 day after intervention; and 6 weeks]

      Pain Catastrophizing Scale. Catastrophic thinking has widely been recognized in the development and maintenance of hypochondriasis and anxiety disorders.The PCS is a 13 item scale, with each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time). The PCS is broken into three subscales being magnification, rumination, and helplessness. The scale was developed as a self-report measurement tool that provided a valid index of catastrophizing in clinical and non-clinical populations. ranges from '0' representing no pain catastrophizing to '52' representing maximum pain catastrophizing

    2. Kinesiophobia: Tampa Scale for Kinesiophobia [baseline; 1 day after intervention; and 6 weeks]

      The Tampa Scale for Kinesiophobia (TSK) is a 17 item questionnaire used to assess the subjective rating of kinesiophobia or fear of movement. ... The TSK is a self-completed questionnaire and the range of scores are from 17 to 68 where the higher scores indicate an increasing degree of kinesiophobia.

    Other Outcome Measures

    1. Quality of live: Questionnaire Euroquol-5D (EQ-5D) [baseline; 1 day after intervention; and 6 weeks]

      The EQ-5D questionnaire has two components: health state description and evaluation. In the description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression The evaluation part is a Visual analogue scale is the second part of the questionnaire, asking to mark health status on the day of the interview on a 20 cm vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine"

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients participating in the "back protocol" groups in the hospital

    • That present pain of more than 3 months of evolution

    Exclusion Criteria:
    • Oncological pain

    • Fracture or spinal surgery in the last year

    • Cognitive neurological alteration that prevents understanding the contents of the session

    • Alterations at the motor level that prevent the realization of the program of directed physical exercise that is currently carried out

    • Pregnancy

    • Urinary or intestinal incontinence

    • Other clinical conditions that may aggravate chronic spinal pain (chronic fatigue syndrome, fibromyalgia and complex regional pain syndrome)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Universitario de San Juande Alicante San Juan De Alicante Alicante Spain 03550

    Sponsors and Collaborators

    • Universidad Miguel Hernandez de Elche
    • Hospital Universitario San Juan de Alicante

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    María Isabel Tomás Rodríguez, Principal Investigator, Universidad Miguel Hernandez de Elche
    ClinicalTrials.gov Identifier:
    NCT03964389
    Other Study ID Numbers:
    • 19/ 317
    First Posted:
    May 28, 2019
    Last Update Posted:
    Nov 6, 2020
    Last Verified:
    Nov 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by María Isabel Tomás Rodríguez, Principal Investigator, Universidad Miguel Hernandez de Elche
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 6, 2020